Nanobiotix S.A. is a biotechnology company focused on developing innovative treatments for cancer by utilizing its proprietary nanotechnology platform

The company aims to enhance the effectiveness of cancer therapies through its lead product candidate, which is designed to improve the tumor's response to radiation therapy. By harnessing the unique properties of nanoparticles, Nanobiotix aspires to provide targeted, localized treatments that minimize damage to surrounding healthy tissue, ultimately improving patient outcomes and quality of life in the fight against cancer.